Fact CheckerSign in

NCT04378855Active, not recruiting

Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY).

Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY): A GIMEMA Observational Registry for Italian MPN Patients

Source: ClinicalTrials.gov · Last updated 23 Sept 2025

Brief summary (registry, in English)

This study will ultimately aim at developing a GIMEMA platform for collecting HRQoL and symptom burden information on Italian patients with Philadelphia chromosome negative MPN. The main objective of the protocol is to improve our understanding of the impact of the disease and various treatments on patients-wellbeing, symptom burden and daily functioning.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
572 (actual)
First submitted
28 Apr 2020
Start date
29 May 2020
Primary completion date
15 Nov 2023
Lead sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
NCT number
NCT04378855

What you commit to

  • Study type: Observational
  • Participants enrolled: 572
  • From 29 May 2020 to the primary completion date, 15 Nov 2023
  • 25 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Having any kind of psychiatric disorder or major cognitive dysfunction problems hampering a self-reported evaluation.

Other

  • Not able to read and understand local language (i.e. Italian).

Who the study is looking for

  • Patients diagnosed with Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Primary Myelofibrosis (pre-PMF, overt-PMF) and post-ET/post-PV Myelofibrosis (MF), (i.e. Philadelphia chromosome negative myeloproliferative neoplasm (MPN)) according to 2016 WHO classification.
  • Known IPSS/IPSET/DIPSS risk score category at time of initial diagnosis of PV, ET and PMF, respectively.
  • Initial diagnosis of MPN within one year before date of registration.
  • Having a full baseline PRO Evaluation completed.
  • Adult patients (≥ 18 years old).
  • Written informed consent provided.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (25)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Aon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia
Coordinator of this site? Confirm its status
AlessandriaItalyUnknown status
Asl Di Asti, Ospedali Riuniti - Presidio Ospedaliero Cardinal G. Massaia - Sc Oncologia
Coordinator of this site? Confirm its status
AstiItalyUnknown status
Irccs Oncologico Istituto Tumori Giovanni Paolo Ii - Bari - Uo Ematologia
Coordinator of this site? Confirm its status
BariItalyUnknown status
Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto
Coordinator of this site? Confirm its status
BariItalyUnknown status
Istituto di Ematologia "Lorenzo e A. Seragnoli"
Coordinator of this site? Confirm its status
BolognaItalyUnknown status
Ao Brotzu, Presidio Ospedaliero A. Businco - Cagliari - Sc Ematologia E Ctmo
Coordinator of this site? Confirm its status
CagliariItalyUnknown status
Aou Careggi - Firenze - Sod Ematologia
Coordinator of this site? Confirm its status
FlorenceItalyUnknown status
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia- Padiglione Marcora 2° piano
Coordinator of this site? Confirm its status
MilanItalyUnknown status
Aou Di Modena - Sc Ematologia
Coordinator of this site? Confirm its status
ModenaItalyUnknown status
Azienda Ospedaliera "S.Gerardo"
Coordinator of this site? Confirm its status
MonzaItalyUnknown status
Aou Federico Ii - Napoli - Uoc Ematologia
Coordinator of this site? Confirm its status
NaplesItalyUnknown status
.C.D.U. Ematologia - Università del Piemonte Orientale Amedeo Avogadro
Coordinator of this site? Confirm its status
NovaraItalyUnknown status
Aou Policlinico P. Giaccone - Palermo - Uo Ematologia
Coordinator of this site? Confirm its status
PalermoItalyUnknown status
Fondazione Ircss Policlinico San Matteo - Pavia - Uo Ematologia
Coordinator of this site? Confirm its status
PaviaItalyUnknown status
Aou Pisana - Uo Ematologia Universitaria
Coordinator of this site? Confirm its status
PisaItalyUnknown status
Ausl Di Reggio Emilia - Arcispedale Santa Maria Nuova, Irccs - Sc Ematologia
Coordinator of this site? Confirm its status
Reggio EmiliaItalyUnknown status
Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia
Coordinator of this site? Confirm its status
RiminiItalyUnknown status
C.R.O.B. - I.R.C.C.S. - Rionero in Volture - Uoc Ematologia
Coordinator of this site? Confirm its status
Rionero in VultureItalyUnknown status
Asl Roma 2, Ospedale S. Eugenio- Ospedale S.Eugenio - Uoc Ematologia
Coordinator of this site? Confirm its status
RomaItalyUnknown status
Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica
Coordinator of this site? Confirm its status
RomaItalyUnknown status
Università Degli Studi Di Roma "Sapienza" - Dipartimento Di Medicina Traslazionale E Di Precisione - U.O.C. Ematologia
Coordinator of this site? Confirm its status
RomaItalyUnknown status
Aou Di Sassari - Cliniche Universitarie - Stabilimento Cliniche Di San Pietro - Uoc Ematologia
Coordinator of this site? Confirm its status
SassariItalyUnknown status
Ospedale Mauriziano Umberto I - Torino - Scdu Ematologia
Coordinator of this site? Confirm its status
TorinoItalyUnknown status
Aou Città Della Salute E Della Scienza, Ospedale S. Giovanni Battista Molinette - Torino - Sc Ematologia - Università Degli Studi Di Torino
Coordinator of this site? Confirm its status
TorinoItalyUnknown status
Asl to 2, Torino Nord Emergenza San Giovanni Bosco - Ssd Ematologia
Coordinator of this site? Confirm its status
TorinoItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.